What are the proper storage and transport conditions for cryoprecipitate (cryoprecipitated antihemophilic factor)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cryoprecipitate Storage and Transport Guidelines

Cryoprecipitate must be stored at -25°C or below in a frozen state, and once thawed, it can be kept at ambient temperature for up to 4 hours and should not be refrigerated again. 1

Storage Requirements

Frozen Storage

  • Cryoprecipitate must be maintained at a core temperature below -25°C
  • Can be stored frozen for up to 36 months 1
  • Requires specialized freezers capable of maintaining this temperature consistently

Thawing Process

  • Thawing methods include:
    • Dry ovens
    • Microwave ovens
    • Water bath methods 1
  • Thawing should be done carefully to preserve coagulation factor activity
  • Cryoprecipitate is produced by thawing FFP at 1-6°C, which precipitates high-molecular-weight plasma proteins 2, 3

Post-Thaw Handling

Time and Temperature Limitations

  • Once thawed, cryoprecipitate can be kept at ambient temperature for only 4 hours 1
  • Should not be refrigerated after thawing 1
  • Must be transfused within this 4-hour window to ensure optimal coagulation factor activity

Transport Considerations

  • Transport time outside temperature-controlled environments should be minimized
  • Must be administered using a standard blood giving set with a 170-200 μm filter 1
  • Typical infusion rate is 10-20 ml/kg/h (30-60 minutes for one pool) 1

Quality Standards

  • 75% of cryoprecipitate units should contain at least 140 mg of fibrinogen
  • Pooled cryoprecipitate (from five donations) should contain >700 mg of fibrinogen 1
  • Each single unit contains 400-450 mg of fibrinogen 1
  • Contains concentrated factor VIII, von Willebrand factor, fibrinogen, factor XIII, and fibronectin 1, 2, 3

Special Considerations

Pediatric Use

  • Cryoprecipitate for use in those born in 1996 or later (in the UK) is made from FFP sourced outside the UK and has undergone viral inactivation with methylene blue 1
  • Available as single units for smaller children and pooled units for older children and young adults 1

Recent Research on Extended Storage

While current guidelines limit post-thaw storage to 4 hours at ambient temperature, recent research suggests potential for extended storage:

  • Studies have shown that refrigerated storage (1-6°C) of thawed cryoprecipitate for up to 24 hours maintains fibrinogen levels and von Willebrand factor activity, though Factor VIII activity decreases significantly 4
  • Some research indicates fibrinogen concentration and function may remain adequate for up to 35 days when refrigerated 5
  • Extended storage at 2-6°C for up to 5 days has shown maintenance of coagulation factors above therapeutic ranges 6

However, current clinical guidelines still recommend the 4-hour limit at ambient temperature, and these research findings have not yet been incorporated into standard practice.

Common Pitfalls to Avoid

  • Refrigerating thawed cryoprecipitate (should be kept at ambient temperature)
  • Exceeding the 4-hour post-thaw window for administration
  • Using improper filters for administration
  • Failing to complete transfusion within the recommended timeframe
  • Not properly monitoring for precipitation in stored units (precipitation may occur in refrigerated samples but can be resuspended upon warming in a 37°C water bath) 5

By adhering to these storage and transport guidelines, the efficacy of cryoprecipitate can be maintained, ensuring optimal outcomes when used for its various clinical indications.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.